Authors:
Nolan T.; Richmond P.; Marshall H.; ...; et al.
Authors notes:
Pediatric Infectious Diseases Journal 2011; 30:190-196 (Impact factor 2.854)
Keywords:
Immunogenicity, safety, combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y- tetanus toxoid conjugate (HibMenCY-TT) vaccine, infants
Abstract:
Neisseria meningitidis serogroups B, C, and Y cause most meningococcal disease in industrialized countries. A Haemophilus influenzae type b-meningococcal serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) was evaluated.